title: Intravitreal injection of bevacizumab induces inflammatory alterations in a uveitis experimental model.
authors.affiliation: Fundación Oftalmológica del Mediterráneo (FOM), Valencia, Spain.
authors.forename: Siv
authors.initials: S
authors.lastname: Johnsen-Soriano
authors.forename: Emma
authors.initials: E
authors.lastname: Arnal
authors.forename: María
authors.initials: M
authors.lastname: Sancho-Tello
authors.forename: María
authors.initials: M
authors.lastname: Muriach
authors.forename: Inmaculada
authors.initials: I
authors.lastname: Almansa
authors.forename: Francisco
authors.initials: F
authors.lastname: Bosch-Morell
authors.forename: Amparo
authors.initials: A
authors.lastname: Navea
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Romero
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D001082:Aqueous Humor / Q000378:metabolism*; D000068258:Bevacizumab; D018932:Chemokine CCL2 / Q000378:metabolism; D018946:Chemokine CCL5 / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism*; D004195:Disease Models, Animal; D004797:Enzyme-Linked Immunosorbent Assay; D007371:Interferon-gamma / Q000378:metabolism; D058449:Intravitreal Injections; D008070:Lipopolysaccharides; D008297:Male; D051381:Rats; D011917:Rats, Inbred Lew; D014605:Uveitis / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C491766:Ccl2 protein, rat; D018932:Chemokine CCL2; D018946:Chemokine CCL5; D016207:Cytokines; D008070:Lipopolysaccharides; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D007371:Interferon-gamma